Literature DB >> 6261053

Metastatic malignant disease to the parotid gland.

C T Yarington.   

Abstract

A survey of over 250 consecutive parotidectomies performed at The Mason Clinic indicates a surprising incidence of metastatic malignant disease to the parotid gland. Four percent of all parotidectomies performed indicated a metastatic focus of malignancy from an ;unsuspected primary outside areas of the head and neck usually implicated in parotid disease. Twenty-five percent of all cancer discovered at parotidectomy was metastatic malignant disease to the parotid gland. The most common site was the lung. A high index of suspicion, evaluation of pathologic specimens by electron microscopy, and detailed metastatic work-up for patients with malignant disease in parotid lymph nodes are recommendations which should be considered by the surgeon performing parotid procedures.

Entities:  

Mesh:

Year:  1981        PMID: 6261053     DOI: 10.1288/00005537-198104000-00004

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  2 in total

1.  p63 immunohistochemistry differentiates salivary gland oncocytoma and oncocytic carcinoma from metastatic renal cell carcinoma.

Authors:  Jonathan B McHugh; Aaron P Hoschar; Mari Dvorakova; Anil V Parwani; E Leon Barnes; Raja R Seethala
Journal:  Head Neck Pathol       Date:  2007-10-26

2.  Deep lobe parotidectomy-why, when, and how?

Authors:  Kerry D Olsen; Miquel Quer; Remco de Bree; Vincent Vander Poorten; Alessandra Rinaldo; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-10-12       Impact factor: 2.503

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.